Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Meningeal Carcinomatosis × Trastuzumab × Clear all

Phase

Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 266 Stomach Neoplasms 31 Neoplasm Metastasis 21 Neoplasms 15 Breast Neoplasms, Male 14 Colorectal Neoplasms 13 HER2-positive Breast Cancer 11 Triple Negative Breast Neoplasms 8 Esophageal Neoplasms 8 Inflammatory Breast Neoplasms 7 Brain Neoplasms 7 Rectal Neoplasms 6 Adenocarcinoma 6 Pathologic Complete Response 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Salivary Gland Neoplasms 4 Gallbladder Neoplasms 4 Biliary Tract Neoplasms 4 Urologic Neoplasms 3 Urinary Bladder Neoplasms 3 Recurrence 3 Neoplastic Cells, Circulating 3 Meningeal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Ductal, Breast 3 Sarcoma 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2

Interventions

Pemetrexed 5 Bevacizumab 5 osimertinib 3 Temozolomide 3 trastuzumab deruxtecan 2 aflutinib 2 Topotecan 2 Spinal Puncture 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Methotrexate 2 Magnetic Resonance Spectroscopy 2 tucatinib 1 trioctyl phosphine oxide 1 pembrolizumab 1 nimotuzumab 1 merphos 1 lenvatinib 1 glutathione pegylated liposomal doxorubicin 1 epothilone B 1 envafolimab 1 camrelizumab 1 Trastuzumab 1 Transplantation, Autologous 1 Radiotherapy 1 Radiosurgery 1 Nivolumab 1 Ipilimumab 1 Etoposide 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05800275 2025-11-18

ETIC-LM

UNICANCER

Phase 2 Recruiting

Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡